Last updated on February 2018

Clinical Trial of Gene Therapy for the Treatment of Leber Congenital Amaurosis (LCA)

Brief description of study

A clinical trial of AAV2/5 vector for patients with Defects in RPE65

Detailed Study Description

A dose escalation and dose expansion (Phase I/II) trial of adults and children with retinal dystrophy associated with defects in RPE65. ATIMP will be administered to one eye only in a single sub-retinal procedure

Clinical Study Identifier: NCT02781480

Find a site near you

Start Over

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.